Lb Pharmaceuticals LBRX Cash Flow Statement (2024-2026)

NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Lb Pharmaceuticals Quarterly Cash Flow Statement

Periods 9 quarters
Latest Sep 2026

Lb Pharmaceuticals reported cash from operations of -$64.29M and free cash flow of -$64.36M for the quarter ended Sep 2026. This cash flow statement covers 9 quarters of results from Sep 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income -14.18M-5.07M-5.31M-4.87M-3.56M-11.47M-19.05M-51.60M-59.07M
Depreciation and DepletionDep. & Depletion 0.08M0.08M0.08M0.08M0.10M0.12M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.08M0.08M0.08M0.08M0.10M0.12M
Share-based CompensationStock Comp. 2.28M0.63M0.34M0.88M2.34M2.57M4.90M3.67M
Gains from Investment SecuritiesGains Investment 1.71M0.77M-0.19M-0.40M0.20M-0.66M0.00M
Other non-cash itemsOther Non-Cash 0.13M0.13M-0.08M0.05M0.05M0.05M0.09M0.10M
Change in Working Capital 378.50M331.70M416.90M
Change in Accrued ExpensesChange Accrued Exp. -2.93M-2.89M-1.55M1.57M1.97M3.46M12.54M6.02M
Change in Other Operating AssetsOther Assets Change -0.01M-0.08M-0.24M1.37M11.30M10.22M4.07M15.27M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M0.00M0.06M-0.09M-0.10M-0.10M-0.06M-0.06M
Other Working Capital ChangesOther WC Changes 0.01M0.09M0.30M-1.46M-11.40M-10.32M-4.13M-15.33M
Cash from OperationsCash from Ops. -5.67M-8.13M-5.60M-3.37M-18.10M-23.30M-37.62M-64.29M
Investing Activities
Capital ExpendituresCapex 1.40M0.02M-0.01M0.04M0.03M0.36M0.07M
Change in Property, Plant and EquipmentChange in PP&E -1.40M-0.02M0.01M-0.04M-0.03M-0.36M-0.07M
Purchase of InvestmentsInvestments Purchased 44.84M156.40M
Sale and Maturity of InvestmentsInvestments Sold 13.78M5.00M45.04M55.24M
Cash from Investing ActivitiesCash from Investing 13.54M4.98M0.01M-44.84M-0.04M-0.03M0.09M-144.65M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 302.32M100.03M0.05M150.04M
Shares Repurchased -1.17M
Net Shares Issued and RepurchasedNet Shares Issued 302.32M1.17M100.03M0.05M150.04M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued 0.100.100.10
Net Equity Issued and RepurchasedNet Equity Issued 302.32M1.17M100.03M0.05M150.04M
Other financing activities (as filed) -24.27M-1.17M-6.20M-0.07M6.27M
Cash from Financing ActivitiesCash from Financing 303.73M-1.17M93.83M-0.02M140.92M
Additional items
Change in Cash 7.87M-3.15M-5.60M255.52M-19.31M70.51M-37.56M-68.03M
Ending Cash Balance 15.60M23.48M20.33M14.73M270.26M250.94M321.45M283.89M215.86M
Free Cash FlowFCF -7.06M-8.15M-5.60M-3.37M-18.14M-23.33M-37.98M-64.36M
Net Cash FlowNCF 7.87M-3.15M-5.60M255.52M-19.31M70.50M-37.55M-68.03M
Income Taxes PaidTaxes Paid -2.40M0.00M

Lb Pharmaceuticals Cash Flow Statement API

Pull Lb Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LBRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY